On April 12, 2023, NBC News published the article “What the Supreme Court’s decision in the legal fight over abortion pills means for access to mifepristone.” After a federal judge in Texas ruled to pause the FDA’s approval of mifepristone, one of two drugs used in medication abortions, the Justice Department appealed the decision. The ruling has been placed on hold until the case is tried by the Fifth Circuit Court of Appeals, which will begin hearing oral arguments on May 17. This article features the insight of Wendy Parmet, director of the Northeastern Center for Health Policy and Law and WGSS affiliated faculty member. Parmet explained, “This is opening the door to basically anybody challenging any drug that they disapprove of on the theory that somebody might get hurt. No one denies that there are adverse consequences, adverse effects to any medication, including any over-the-counter painkiller or cold medication. That those people might end up in these plaintiffs’ offices and somehow it will affect these doctors’ ability to practice and their relationship with their patients — that’s just absurd.”
Read the full article in NBC News here!
Image credits: NBC News